iShares World ex U.S. Carbon Transition Readiness Aware Active ETF (LCTD)
Live price chart, market sentiment, and community perspectives for iShares World ex U.S. Carbon Transition Readiness Aware Active ETF (AMEX: LCTD).
Live price chart, market sentiment, and community perspectives for iShares World ex U.S. Carbon Transition Readiness Aware Active ETF (AMEX: LCTD).
On our desk, we've been tracking the institutional flow for LCTD closely through Q2 2026. With 107 funds holding $179M and new positions outnumbering exits, the macro narrative around carbon transition readiness is pulling steady capital. Even though near-term technical readings show a mid-channel oscillation, the broader accumulation trend gives us confidence to maintain a constructive long-term stance.
Reviewing Morningstar's risk metrics for LCTD, the fund scores a 70, placing it in the aggressive tier. While standard deviation sits at 12.80 and beta is 0.86, the trailing 3-year total return of 14.74 trails the category average of 16.72. Risk managers must weigh these performance lags against the underlying active management strategy.
Watching the quantitative signals on LCTD, our models indicate an exceptional risk-reward setup with downside parameters constrained to around 0.3% versus upside targets ranging from 3.2% to 4.0%. When trading this mid-channel pattern, execution precision around the 56 to 60 price band is crucial for optimizing position sizing.
Analyzing the cost structure from the May 2026 summary prospectus, LCTD operates with a net expense ratio of 0.22% (against a gross expense ratio of 0.37%). For an active ETF focusing on international carbon transition readiness, this fee profile remains competitive, though investors should closely monitor the 30-day SEC yield of 2.07% as rate environments shift.
From a market sentiment perspective, short interest on LCTD dropped by 27.1% down to just 10,261 shares in March, resulting in a days-to-cover ratio of a mere 0.7 days. With only 0.2% of shares shorted, downward pressure from bearish speculators is practically non-existent, leaving the ETF exposed primarily to broader equity market direction.
Explore plasma cleansing, somatic organ swaps, and BCI.